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The intracellular distribution of DNA methyltransferase has been analyzed in synchronously proliferating human cells. 
The localization of DNA methyltransferase was determined immunocytochemically using monoclonal antibodies directed 
against this enzyme. DNA methyltransferase was found to accumulate predominantly in nuclei with weak cytoplasmic 
staining. The DNA methyltransferase antigen was absent in early G, phase, appeared in late G, prior to the onset of 
DNA synthesis and persisted throughout S and GZ phases of the cell cycle. Mitotic cells showed a particularly strong 
staining intensity. These results show that DNA methyltransferase levels fluctuate during the cell cycle. This has possible 
implications on the stability of the DNA methylation pattern. 
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1. INTRODUCTION 
The function of DNA methylation in mammals, 
although still a subject of debate, is in many cases 
related to regulation of gene expression (reviewed 
in [1,2]). The clonal stability of DNA methylation 
patterns is guaranteed by a DNA methylating en- 
zyme, which transfers methyl groups to 
hemimethylated 5 ’ -CpG-3 ’ dinucleotides shortly 
after DNA replication. This enzyme, DNA 
cytosine-5-methyltransferase (DNA methyltrans- 
ferase, EC 2.1.1.37) strongly prefers hemimethyl- 
ated over unmethylated DNA substrates and its 
activity resides in a single polypeptide of 190 kDa 
[3]. However, the enzyme possesses a considerable 
de novo DNA methyltransferase activity in vitro, 
which transfers methyl groups to previously 
unmethylated sites [4-71. This de novo activity is 
assumed to be suppressed in the cell in order to 
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avoid changes of the DNA methylation pattern ex- 
cept in certain stages of differentiation and 
development, when the methylation pattern is 
specifically altered [8]. In non-proliferating cells, 
where apart from DNA repair processes the DNA 
methylating enzyme is obviously dispensable, the 
level of DNA methyltransferase was shown to be 
indeed extremely low [3,9,10]. DNA methyltrans- 
ferase activity increases dramatically, when cells 
are exposed to a proliferation stimulus [9, lo]. The 
availability and distribution of DNA methyltrans- 
ferase within the cell may be an important factor 
for the control of methyl group transfer reactions 
with important implications on the stability of 
DNA methylation patterns. 
Here, we have analyzed the intracellular 
distribution of DNA methyltransferase in syn- 
chronously proliferating human carcinoma cells by 
immunocytochemical techniques. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
HeLa cells (ATCC, CCL2, obtained from Flow Laborato- 
ries) and HEp-2 cells (ATCC, CCL23, obtained from Flow 
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Laboratories) were grown at 37°C as monolayers in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% 
fetal calf serum and antibiotics (penicillin, 100 units/ml; strep- 
tomycin, 100 /g/ml). 
2.2. Cell synchronisation 
Cells were synchronized by selection of accumulated mitotic 
cells [ll]. The cell monolayers were incubated for 12 h in the 
presence of colcemid (0.005 pg/ml medium). Mitotic cells were 
detached from the plastic surface by shaking the dishes and col- 
lected by centrifugation. The cells were resuspended in culture 
medium and plated onto microscopic slides at a concentration 
of 1 x 10’ cells/ml. Between 80 and 90% of the plated cells were 
identified as mitotic cells. The cells were grown for one cell cy- 
cle (22 h) and were then processed for immunocytochemistry 
and thymidine incorporation studies. 
2.3. Cell cycle monitoring 
At 3 h intervals, slides were tested for thymidine incorpora- 
tion as follows: the cells were incubated with 1 pCi 
[‘Hlthymidine (Amersham Buchler, spec. act. 93 Ci/mmol) in 
1 ml medium for 1 h at 37°C. After removal by trypsinisation, 
cells were washed in phosphate buffered saline (PBS) and 
disrupted in 0.5 N NaOH. Radioactivity in perchloric acid- 
insoluble material was determined by liquid scintillation 
counting. 
2.4. Immunocytochemistry 
After the indicated time periods (3 h intervals), the 
microscopic slides were washed in PBS. Cells were fixed in ab- 
solute methanol for 10 min at room temperature. Non-specific 
binding was blocked by preincubating the slides in PBS contain- 
ing 1% horse serum. The slides were then incubated for 1 h at 
room temperature with purified monoclonal anti-DNA 
methyltransferase antibody MlF6D7/5ClO [12] at a concentra- 
tion of 10 gg/ml (unless otherwise indicated) in PBS. Immune 
complexes were visualized with biotinylated horse anti-mouse 
IgG followed by peroxidase reaction with diaminobenzidine as 
substrate (Vectastain@ , Vector Laboratories). The slides were 
dehydrated in graded ethanol and mounted in Eukitt@ . As a 
control for unspecific binding the monoclonal anti-DNA 
methyltransferase antibody was omitted or substituted by nor- 
mal mouse serum. None of the controls yielded a positive stain- 
ing reaction. 
3. RESULTS 
Cultures of human carcinoma cell lines HeLa 
and HEp-2 were synchronized by the mitotic 
detachment echnique. The cells were allowed to 
grow for one cell cycle and were analyzed for the 
presence of DNA methyltransferase antigen in the 
second cell cycle after synchronisation. Progres- 
sion of synchronized cells through the cell cycle 
was monitored by thymidine pulse labelling at in- 
dicated time periods (fig.1). In HeLa cells, DNA 
synthesis started to increase significantly after 
about 8-9 h and in HEp-2 cells lo-12 h after the 
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Fig. 1. Monitoring of the cell cycle by thymidine pulse labelling. 
HeLa cells (m) and HEp-2 cells (0) were pulse labelled in the 
second synchronized cell cycle with [3H]thymidine as described 
in section 2. 
beginning of the second cell cycle. Maximal rates 
of DNA synthesis were measured after 15 h in both 
cell types. 
The cells were processed for immunocytochem- 
istry at 3 h intervals. HeLa cells are shown in fig.2, 
HEp-2 cells in fig.3. No immunocytochemical 
signal was obtained in postmitotic early Gr-phase 
cells (figs 2A and 3A). Cells in late Gr phase 
showed a significant staining of nuclei and a weak 
staining of cytoplasmic regions (figs 2B and 3B). 
At the time point of the maximal rate of DNA syn- 
thesis, the nuclei showed an intense granular 
staining pattern (figs 2C and 3C). This pattern re- 
mained almost unchanged throughout later S 
phase and GZ phase of the cell cycle (fig.3D). In 
figs 2D and 3D some mitotic cells are visible. They 
show a particularly strong accumulation of the 
DNA methyltransferase antigen (fig.3D). When 
more diluted antibody solutions are used, the con- 
densed chromosomes are predominantly stained in 
mitotic cells (fig.2D). Very similar cell cycle- 
dependent distribution patterns of the DNA 
methyltransferase antigen were obtained in HeLa 
and HEp-2 cells (figs 2 and 3) and in a human 
melanoma cell line (not shown). 
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Fig.2. Cell cycle-dependent distribution of DNA methyltransferase in HeLa cells. (A) Cells in early GI phase (3 h); (B) late GI phase 
(6 h); (C) S phase (15 h); (D) mitotic cells (24 h). The concentration of monoclonal antibodies in (D) was 1 ,ug/ml. The cell in the right 
upper part belongs to either the GZ phase or very early GI phase. Bar, 20 pm. 
4. DISCUSSION 
DNA methyltransferase is nonrandomly distrib- 
uted throughout the different phases of the cell cy- 
cle. The localization of the DNA methyltransferase 
antigen is predominantly nuclear, which is consis- 
tent with biochemical investigations using different 
cellular compartments for extraction and activity 
determination [121. Our immunocytochemical data 
show that DNA methyltransferase is absent in ear- 
ly Gr phase, appears in late Gr, and accumulates 
and persists throughout S and G2 phases of the cell 
cycle. The presence of DNA methyltransferase in 
the G2 phase may explain the phenomenon of 
delayed DNA methylation occurring several hours 
after replication [ 131. Mitotic cells are characteris- 
tic for a strong immunochemical staining. This 
may be due to a release of the DNA methyltrans- 
ferase antigen from nuclear structures which are 
inaccessible for the anti-DNA methyltransferase 
antibody in interphase cells. Indeed, it has been 
shown that DNA methyltransferase is associated 
with nuclear matrix like structures [12-141, 
although the amounts of enzyme present within 
these structures are difficult to quantify. The 
absence of the DNA methyltransferase antigen in 
early Gr phase implies that the enzyme disappears 
shortly after completion of cell division either by 
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Fig.3. Cell cycle-dependent distribution of DNA methyltransferase in HEp-2 cells. (A) Cells in early GI phase (3 h); (B) late G1 phase 
(6 h); (C) S phase (15 h); (D) late S and GZ phase (21 h). The arrow indicates a mitotic cell. Bar, 20pm. 
redistribution into antibody-inaccessible structures 
or by a rapid decomposition. 
In previous studies, DNA methyltransferase 
levels have been analyzed in peripheral lym- 
phocytes before and after mitogen stimulation. 
Activity determination [lo] and immunocytochem- 
ical studies [9] have shown that DNA methyltrans- 
ferase is absent in unstimulated peripheral lympho- 
cytes but appears just prior to the onset of DNA 
synthesis. DNA methyltransferase levels were 
found to be coupled to proliferation also in 
hepatectomized rat livers [lo]. Analysis of DNA 
methyltransferase activities throughout the HeLa 
cell cycle presented evidence for two activity peaks, 
one in G1 phase, and a second in S phase [15]. Our 
system determining antigen concentrations did not 
show a biphasic distribution. Delfini et al. [15] 
have used double thymidine block for cell synchro- 
nisation. Their results also indicate the absence of 
DNA methyltransferase in early G1 phase. The 
fluctuation of DNA methyltransferase levels 
throughout the cell cycle resembles the cell cycle- 
dependent appearance of a number of other en- 
zymes and proteins involved in DNA synthesis. 
Similar to DNA methyltransferase, the levels of 
DNA topoisomerase II are very low in early 
Gl-phase cells [16]. The amount of DNA 
polymerase cy increases rapidly during S phase, but 
unlike DNA methyltransferase the polymerase is 
redistributed to the daughter cells after mitosis and 
12 
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persists there through the whole GI phase [ 171. The 
DNA polymerase g interacting replication factor 
cyclin is detectable only in S-phase cells [18]. 
The fluctuation of DNA methyltransferase dur- 
ing the cell cycle may be of considerable regulatory 
importance. In early Gr-phase cells and also in 
non-replicating cells (GO cells) DNA methyltrans- 
ferase is obviously dispensable xcept for methyla- 
tion of DNA repair patches (although it is not 
known, whether one and the same enzyme is 
responsible for methylation in replication and 
repair processes). An important question pertinent 
to our understanding of the stability of DNA 
methylation patterns is: How is the de novo activi- 
ty of DNA methyltransferase suppressed in the 
cell? It is clear that one way to achieve this sup- 
pression and to exclude inappropriate changes of 
the DNA methylation pattern is to avoid the 
presence of the enzyme at possible de novo 
methylation sites. This functional aspect may 
underlie the fluctuation of DNA methyltransferase 
levels during the cell cycle. 
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